ALLMedicine™ Gout Center
Research & Reviews 6,613 results
https://doi.org/10.1007/s40620-020-00937-4 10.1038/sj.ki.5002343 10.1161/CIRCULATIONAHA.113.007106 10.1016/S0140-6736(13)60595-4 10.1159/000331453 10.1291/hypres.24.691 10.1152/ajprenal.00104.2008 10.1152/ajprenal.00164.2006 10.1111/j.1523-1755.2005.00074.x 10.1053/j.ajkd.2008.12.021 10.1161/01.CIR.0000046448.26751.58 10.2215/CJN.01580210 10.1053/j.ajkd.2005.10.006 10.1186/s12882-017-0607-5 10.1371/journal.pone.0170393 10.1186/s12882-015-0047-z 10.1056/NEJMoa1915833 10.2337/dc19-0342
Journal of Nephrology; Jeyaruban A, Hoy W et. al.
Jan 13th, 2021 - There is scant data on the role of hyperuricaemia, gout and allopurinol treatment in chronic kidney disease (CKD). Therefore, our aim is to investigate the possible associations between hyperuricaemia, gout, prescription of allopurinol and renal o...
https://doi.org/10.1124/molpharm.120.000086
Molecular Pharmacology; Tang LWT, Verma RK et. al.
Jan 13th, 2021 - Benzbromarone (BBR), a potent uricosuric agent for the management of gout, is known to cause fatal fulminant hepatitis. While the mechanism of BBR-induced idiosyncratic hepatotoxicity remains unelucidated, cytochrome P450 enzyme (CYP450)-mediated ...
https://doi.org/10.1002/art.41641
Arthritis & Rheumatology (Hoboken, N.J.); Kharouf F, Azraq Y et. al.
Jan 11th, 2021 - A 44-year-old male presented with a 4-week history of painful contractures in both elbows and left knee. His medical record was notable for metabolic syndrome and antiphospholipid syndrome, with a previous extensive right leg thrombotic event, nec...
https://www.ncbi.nlm.nih.gov/pubmed/33427618
Clinical and Experimental Rheumatology; Mandell BF, Fields TR et. al.
Jan 11th, 2021 - To determine factors associated with gout flares in subjects treated with pegloticase. Gout flares from two randomised controlled trials comparing pegloticase (8 mg every 2 weeks [q2] or monthly [q4]) versus placebo were analysed. Responders had p...
https://doi.org/10.1016/j.ecoenv.2020.111886
Ecotoxicology and Environmental Safety; Jiang A, Zhang Y et. al.
Jan 9th, 2021 - Molybdenum (Mo) is not only an important rare metal that is widely used in industrial production but also an essential trace element for plants and animals. Nevertheless, in Mo polluted areas, excess Mo intake will not only cause gout in humans bu...
Guidelines 47 results
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/
Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...
https://www.jwatch.org/na51787/2020/06/11/managing-gout
NEJM Journal Watch;
Jun 10th, 2020 - The ACR has updated its 2012 guideline on managing gout. Each recommendation is rated as “strong” (supported by moderate- or high-certainty evidence) or “conditional” (benefits and risks are closely balanced, or only low-certainty evidence or no d...
https://doi.org/10.1002/art.41247
Arthritis & Rheumatology (Hoboken, N.J.) References; FitzGerald JD, Dalbeth N et. al.
May 11th, 2020 - To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. Fifty-seven population, intervention, comparat...
http://www.jrheum.org/content/47/4/619.long
The Journal of Rheumatology; Russell MD
Mar 31st, 2020 - To describe trends in acute hospital admissions due to gout in England, with rheumatoid arthritis (RA) as a comparator, alongside prescribing trends for common gout medications.
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
New England Journal of Medicine; Tardif JC et al
Nov 16th, 2019 - Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
Drugs 563 results see all →
Clinicaltrials.gov 7,989 results
https://doi.org/10.1007/s40620-020-00937-4 10.1038/sj.ki.5002343 10.1161/CIRCULATIONAHA.113.007106 10.1016/S0140-6736(13)60595-4 10.1159/000331453 10.1291/hypres.24.691 10.1152/ajprenal.00104.2008 10.1152/ajprenal.00164.2006 10.1111/j.1523-1755.2005.00074.x 10.1053/j.ajkd.2008.12.021 10.1161/01.CIR.0000046448.26751.58 10.2215/CJN.01580210 10.1053/j.ajkd.2005.10.006 10.1186/s12882-017-0607-5 10.1371/journal.pone.0170393 10.1186/s12882-015-0047-z 10.1056/NEJMoa1915833 10.2337/dc19-0342
Journal of Nephrology; Jeyaruban A, Hoy W et. al.
Jan 13th, 2021 - There is scant data on the role of hyperuricaemia, gout and allopurinol treatment in chronic kidney disease (CKD). Therefore, our aim is to investigate the possible associations between hyperuricaemia, gout, prescription of allopurinol and renal o...
https://doi.org/10.1124/molpharm.120.000086
Molecular Pharmacology; Tang LWT, Verma RK et. al.
Jan 13th, 2021 - Benzbromarone (BBR), a potent uricosuric agent for the management of gout, is known to cause fatal fulminant hepatitis. While the mechanism of BBR-induced idiosyncratic hepatotoxicity remains unelucidated, cytochrome P450 enzyme (CYP450)-mediated ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d06db628-f6f0-48e2-b538-69c0837c49e3
Jan 13th, 2021 - Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: •rheumatoid arthritis •osteoarthritis •ankylosing spondylitis •Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodiu...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96ca32da-68cc-d757-e053-2995a90a76d8
Jan 13th, 2021 - Colchicine Tablets, USP are indicated for prophylaxis and the treatment of acute gout flares. Prophylaxis of Gout Flares: Colchicine Tablets, USP are indicated for prophylaxis of gout flares. Treatment of Gout Flares: Colchicine Tablets, USP are i...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a548d1-97c0-46d0-825a-75ef689d6470
Jan 13th, 2021 - Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium ta...
News 1,217 results
https://www.medscape.com/viewarticle/943485
Jan 3rd, 2021 - Takeaway Cardiovascular comorbidities and chronic kidney disease (CKD) associate with increasing serum urate (SU) in modest (e.g. 1 mg/dl) increments.
https://www.medscape.com/viewarticle/943128
Dec 22nd, 2020 - A recent analysis of the incidence of gout in men, published in JAMA Network Open, offers new insights on the role of lifestyle changes in preventing gout, particularly the importance of obesity and its modification. Prior gout research, although ...
https://www.medscape.com/viewarticle/941885
Dec 1st, 2020 - Public spending on colchicine has grown exponentially over the past decade despite generics suggesting an uphill slog for patients seeking access to long-term therapy for gout or cardiac conditions. Medicaid spending on single-ingredient colchicin...
https://reference.medscape.com/viewarticle/941449
Nov 23rd, 2020 - Guidelines for managing gout were published in June 2020 by the American College of Rheumatology (ACR).[1] Indications for Pharmacologic Urate-Lowering Therapy (ULT) Initiating ULT is strongly recommended for gout patients with ≥1 subcutaneous t...
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/
Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...